PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Octenidine→

Octenidine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
71251-02-0
Molecular formula
C36H62N4
Molecular weight
550.9 g/mol
Drug class
Cationic bispyridine antiseptictopical local anti-infective agent
Mechanism of action
A cationic, surface-active antiseptic that binds to negatively charged microbial cell-wall and membrane components, disrupting membrane integrity and causing leakage of cellular contents. It has broad activity against bacteria and fungi and activity against some enveloped viruses.
Indications / reported uses
  • Antiseptic cleansing and treatment of skin, mucous membranes and wounds in formulations authorised for the relevant route and site.

Sources: https://www.ema.europa.eu/en/documents/mrl-report/octenidine-dihydrochloride-european-public-mrl-assessment-report-epmar-committee-medicinal-products-veterinary-use_en.pdf · https://pubmed.ncbi.nlm.nih.gov/26949863/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC8708894/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Octenidine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Octenidine Permitted Daily Exposure (PDE) report (the Octenidine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Octenidine Occupational Exposure Limit (OEL) report (the Octenidine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.